• Panel Description
  • Test Description
  • CPT Codes

Whole Genome


Panel Description

Generate TRF
Generating ...
Download TRF

Test Description

  • Sequencing (included)
  • Rush /STAT
5 - 8 weeks
Call for details
Call for Details ( Call for Details )
96% at 20x
Blood (two 4ml EDTA tubes, lavender top) or Extracted DNA (3ug in TE buffer) or Buccal Swab or Saliva (kits available upon request)
Whole Genome is a phenotype-driven test for a single individual (proband only). Family history and clinical information is required for all Whole Genome orders. Incidental or secondary findings which do not match the phenotype are not regularly reported. All sequencing technologies have limitations. This analysis is designed to examine noncoding and coding regions. Although our bioinformatics analysis significantly reduce the contribution of pseudogene sequences or other highly-homologous sequences, these may still occasionally interfere with the technical ability of the assay to identify pathogenic variant alleles in both sequencing and deletion/duplication analyses. Sanger sequencing is used to confirm variants with low quality scores and to meet coverage standards. This assay will not detect certain types of genomic alterations which may cause disease such as, but not limited to, translocations or inversions and most repeat expansions (eg. trinucleotides or hexanucleotides). This assay is not designed or validated for the detection of somatic mosaicism or somatic mutations.

Call for details
Sequencing 81229x1, 81415x1
Del/Dup 81229x1, 81415x1
Sequencing & Del/Dup 81229x1, 81415x1

NOTE:  CPTs are based on the genes listed. Adding or removing genes will change the CPTs. In some cases, a CPT may require a specific list of genes while performing both sequencing and deldup to qualify. Fulgent bases the CPT for each Gene on multiple sources: CLAB2016v1, AMA Molecular Pathology Tier 2 Gene Designation Chart, and AMA CPT 2016. Call for more details.


Gene Descriptions